246 related articles for article (PubMed ID: 24215139)
1. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer.
Nguyen DP; Li J; Yadav SS; Tewari AK
BJU Int; 2014 Aug; 114(2):168-76. PubMed ID: 24215139
[TBL] [Abstract][Full Text] [Related]
2. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
3. CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation.
Kuo PL; Shen KH; Hung SH; Hsu YL
Carcinogenesis; 2012 Dec; 33(12):2477-87. PubMed ID: 23027620
[TBL] [Abstract][Full Text] [Related]
4. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells.
Sumitomo M; Tachibana M; Nakashima J; Murai M; Miyajima A; Kimura F; Hayakawa M; Nakamura H
J Urol; 1999 Feb; 161(2):674-9. PubMed ID: 9915481
[TBL] [Abstract][Full Text] [Related]
5. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.
Ammirante M; Luo JL; Grivennikov S; Nedospasov S; Karin M
Nature; 2010 Mar; 464(7286):302-5. PubMed ID: 20220849
[TBL] [Abstract][Full Text] [Related]
6. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and prostate cancer: the role of interleukin 6 (IL-6).
Nguyen DP; Li J; Tewari AK
BJU Int; 2014 Jun; 113(6):986-92. PubMed ID: 24053309
[TBL] [Abstract][Full Text] [Related]
8. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
10. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
[TBL] [Abstract][Full Text] [Related]
11. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
12. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
13. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
17. NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.
Breccia M; Alimena G
Expert Opin Ther Targets; 2010 Nov; 14(11):1157-76. PubMed ID: 20858024
[TBL] [Abstract][Full Text] [Related]
18. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.
Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I
Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348
[TBL] [Abstract][Full Text] [Related]
19. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
Wu JT; Kral JG
J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.
Benitez DA; Hermoso MA; Pozo-Guisado E; Fernández-Salguero PM; Castellón EA
Prostate; 2009 Jul; 69(10):1045-54. PubMed ID: 19301309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
